monoprost augndropar, lausn í stakskammtaíláti 50 míkróg/ml
laboratoires thea* - latanoprostum inn - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml
livostin augndropar, dreifa 0,5 mg/ml
mcneil sweden ab - levocabastinum hýdróklóríð - augndropar, dreifa - 0,5 mg/ml
zaditen augndropar, lausn í stakskammtaíláti 0,25 mg/ml
laboratoires thea s.a.s. - ketotifenum fúmarat - augndropar, lausn í stakskammtaíláti - 0,25 mg/ml
alcaine augndropar, lausn 5 mg/ml
alcon nordic a/s - proxymetacainum hýdróklóríð - augndropar, lausn - 5 mg/ml
alphagan augndropar, lausn 2 mg/ml
abbvie a/s - brimonidinum tartrat - augndropar, lausn - 2 mg/ml
arzotilol (dorzolamid + timolol actavis) augndropar, lausn 20 mg/ml +5 mg/ml
teva b.v.* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml +5 mg/ml
dorzolamide alvogen augndropar, lausn 20 mg/ml
alvogen ehf. - dorzolamidum hýdróklóríð - augndropar, lausn - 20 mg/ml
fixopost (monoprostduo) augndropar, lausn í stakskammtaíláti 50 míkróg/ml + 5 mg/ml
laboratoires thea* - latanoprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml + 5 mg/ml
maxidex augndropar, dreifa 1 mg/ml
novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml
maxitrol augndropar, dreifa
novartis healthcare a/s - neomycinum súlfat; polymyxinum b súlfat; dexamethasonum fosfat - augndropar, dreifa